Live feed06:00:16·223dINSIDERFilingvia QuantisnowAmendment: Director Broshy Eran sold $809,250 worth of Ordinary Shares (45,000 units at $17.98), decreasing direct ownership by 34% to 60,204 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.TBPH· Theravance Biopharma Inc.Health CareOriginal source
